A one-year follow-up study of treatment-compliant suicide attempt survivors: relationship of CYP2D6-CYP2C19 and polypharmacy with suicide reattempts
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A one-year follow-up study of treatment-compliant suicide attempt survivors: relationship of CYP2D6-CYP2C19 and polypharmacy with suicide reattempts
Authors
Keywords
-
Journal
Translational Psychiatry
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-10-18
DOI
10.1038/s41398-022-02140-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immediate and short-term efficacy of suicide-targeted interventions in suicidal individuals: A systematic review
- (2021) Aiste Lengvenyte et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Clinical correlates of augmentation/combination treatment strategies in major depressive disorder
- (2018) M. Dold et al. ACTA PSYCHIATRICA SCANDINAVICA
- Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients
- (2018) Marin M. Jukić et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antidepressants and suicide risk in depression
- (2017) Philppe Courtet et al. World Psychiatry
- Suicide Attempt as a Risk Factor for Completed Suicide: Even More Lethal Than We Knew
- (2016) J. Michael Bostwick et al. AMERICAN JOURNAL OF PSYCHIATRY
- The epidemiology of polypharmacy
- (2016) R. A. Payne CLINICAL MEDICINE
- SUICIDAL DEPRESSED PATIENTS RESPOND LESS WELL TO ANTIDEPRESSANTS IN THE SHORT TERM
- (2016) Jorge Lopez-Castroman et al. DEPRESSION AND ANXIETY
- Reducing Adverse Drug Events
- (2016) Chad Kessler et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014
- (2016) Nadine Shehab et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Different characteristics associated with suicide attempts among bipolar I versus bipolar II disorder patients
- (2016) Kathryn C. Goffin et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Suicide and suicidal behaviour
- (2016) Gustavo Turecki et al. LANCET
- Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment
- (2016) M M Jukić et al. MOLECULAR PSYCHIATRY
- Co-Prescription Trends in a Large Cohort of Subjects Predict Substantial Drug-Drug Interactions
- (2015) Jeffrey J. Sutherland et al. PLoS One
- A combined high CYP2D6-CYP2C19 metabolic capacity is associated with the severity of suicide attempt as measured by objective circumstances
- (2014) E Peñas-Lledó et al. PHARMACOGENOMICS JOURNAL
- Decreased hippocampal volume and increased anxiety in a transgenic mouse model expressing the human CYP2C19 gene
- (2013) A Persson et al. MOLECULAR PSYCHIATRY
- Suicide Reattempters
- (2013) Pablo Mendez-Bustos et al. HARVARD REVIEW OF PSYCHIATRY
- CYP2D6 ultrarapid metabolism and early dropout from fluoxetine or amitriptyline monotherapy treatment in major depressive patients
- (2012) E M Peñas-LLedó et al. MOLECULAR PSYCHIATRY
- Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects
- (2012) S C Sim et al. PHARMACOGENOMICS JOURNAL
- Novel drug metabolism indices for pharmacogenetic functional status based on combinatory genotyping ofCYP2C9,CYP2C19andCYP2D6genes
- (2011) David Villagra et al. Biomarkers in Medicine
- CYP2D6 in the Brain: Impact on Suicidality
- (2011) J C Stingl (formerly Kirchheiner) et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- High risk of lifetime history of suicide attempts among CYP2D6 ultrarapid metabolizers with eating disorders
- (2011) E M Peñas-Lledó et al. MOLECULAR PSYCHIATRY
- CYP2D6and the severity of suicide attempts
- (2011) Eva M Peñas-Lledó et al. PHARMACOGENOMICS
- Suicide Intent Scale in the prediction of suicide
- (2010) J. Stefansson et al. JOURNAL OF AFFECTIVE DISORDERS
- Cytochrome P450 2D6 Phenotype Predicts Antidepressant Efficacy of Venlafaxine
- (2010) Kasia W. Lobello et al. JOURNAL OF CLINICAL PSYCHIATRY
- CYP2C19 variation and citalopram response
- (2010) David A. Mrazek et al. Pharmacogenetics and Genomics
- Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response
- (2010) Ming-Hsien Tsai et al. PHARMACOGENOMICS
- CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and Nicaraguans
- (2010) A LLerena et al. PHARMACOGENOMICS JOURNAL
- High Frequency of Occurrence of CYP2D6 Gene Duplication/Multiduplication Indicating Ultrarapid Metabolism Among Suicide Cases
- (2009) A L Zackrisson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Factors Associated With Multiple Versus Single Episode Suicide Attempts in the 1990–1992 and 2001–2003 United States National Comorbidity Surveys
- (2008) Jina Pagura et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search